<DOC>
	<DOCNO>NCT01722045</DOCNO>
	<brief_summary>This phase 4 , open-label , single arm , multicenter , clinical study patient neovascular AMD design evaluate efficacy safety Intravitreal Aflibercept Injection ( IAI ) administer 2 year , provide clinical information first year trial evaluate adverse effect , , corneal endothelium follow administration IAI .</brief_summary>
	<brief_title>Study Assess Best Corrected Visual Acuity ( BCVA ) Patients With Neovascular Age-Related Macular Degeneration ( AMD ) Who Are Administered VEGF Trap-Eye ( Intravitreal Aflibercept Injection )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>Inclusion criterion include limited : 1 . Men woman great equal 50 year age unilateral neovascular AMD 2 . BCVA ETDRS letter score 73 24 ( 20/40 20/320 ) study eye 3 . Active primary subfoveal choroidal neovascularization ( CNV ) lesion secondary AMD , include juxtafoveal lesion affect fovea evidence FA study eye 4 . The CNV area must least 50 % total lesion size 5 . Willing able comply clinic visit studyrelated procedure 6 . Provide sign informed consent 7 . Provide sign Health Insurance Portability andAccountability Act ( HIPAA ) authorization Exclusion criterion include limited : 1 . Neovascular AMD fellow eye 2 . Corneal endothelial measure judge independent reading center 3 . Any prior use intraocular antiVEGF treatment neovascular AMD either eye 4 . Structural damage center macula study eye likely preclude improvement BCVA follow resolution macular edema 5 . History cataract surgery , intraocular surgery either eye , within 1 year screen 6 . History cataract surgery , intraocular surgery either eye , within 1 year screening , yttrium aluminum garnet ( YAG ) Capsulotomy within 3 month screen 7 . Contact lens wear either eye within 6 month screen 8 . History angle closure glaucoma either eye 9 . Intraocular laser therapy include selective laser trabeculoplasty ( SLT ) , YAG , prophylactic peripheral iridotomy ( PI ) either eye within 1 year screening , YAG Capsulotomy within 3 month screen 10 . History cataract surgery require anterior chamber intraocular lens implant time either eye 11 . Any prior ocular trauma ( blunt penetrate ) either eye 12 . Embedded corneal foreign body either eye 13 . Evidence infectious blepharitis , keratitis , scleritis , conjunctivitis either eye 14 . Ocular medium insufficient quality obtain fundus OCT image study eye 15 . Any prior ocular inflammation/infection either eye within 3 month screen visit 16 . Any prior use amantadine 17 . Significant preretinal fibrosis involve macula study eye ( , opinion investigator , preretinal fibrosis cause distortion traction central macular region may limit vision , induce retinal edema/thickening , beyond due underlie CNV ) 18 . Intraocular pressure ( IOP ) great equal 30 mm Hg study eye screen 19 . Uncontrolled diabetes mellitus ( DM ) ( HbA1c â‰¥8 ) 20 . Current treatment systemic antiVEGF therapeutic screen 21 . Known serious allergy fluorescein sodium injection angiography 22 . Participation investigational study within 30 day prior screen visit involve treatment drug ( exclude vitamin mineral ) device . 23 . Positive serum hCG pregnancy test screen visit</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>AMD</keyword>
</DOC>